Valneva SE (VALN)
NASDAQ: VALN · IEX Real-Time Price · USD
+0.07 (0.79%)
At close: May 17, 2024, 4:00 PM
-0.04 (-0.39%)
After-hours: May 17, 2024, 4:00 PM EDT

Valneva SE Revenue

Valneva SE had revenue of $166.26M in the twelve months ending March 31, 2024, down -58.99% year-over-year. Revenue in the quarter ending March 31, 2024 was $35.60M, a -2.25% decrease year-over-year. In the year 2023, Valneva SE had annual revenue of $170.79M, a decrease of -55.57%.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
617.84M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.


Fiscal Year End Revenue Change Growth
Dec 31, 2023170.79M-213.57M-55.57%
Dec 31, 2022384.36M-11.19M-2.83%
Dec 31, 2021395.55M261.01M194.01%
Dec 31, 2020134.54M-7.26M-5.12%
Dec 31, 2019141.79M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Varex Imaging 855.80M
GeneDx Holdings 221.85M
SI-BONE 144.05M
Harrow Health 138.68M
Calliditas Therapeutics AB (publ) 119.73M
EyePoint Pharmaceuticals 50.02M
Revenue Rankings